Cepharanthine Prevents Estrogen Deficiency-Induced Bone Loss by Inhibiting Bone Resorption.

about

Boldine Ameliorates Estrogen Deficiency-Induced Bone Loss via Inhibiting Bone Resorption

P2860

Q57111009-2C474055-1767-49A7-A8D3-2A59E566B02C

P2860

Cepharanthine Prevents Estrogen Deficiency-Induced Bone Loss by Inhibiting Bone Resorption.

Item

http://www.wikidata.org/entity/Q52595231

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Cepharanthine Prevents Estroge ...... by Inhibiting Bone Resorption.

@en

Cepharanthine Prevents Estroge ...... by Inhibiting Bone Resorption.

@nl

type

Item

label

Cepharanthine Prevents Estroge ...... by Inhibiting Bone Resorption.

@en

Cepharanthine Prevents Estroge ...... by Inhibiting Bone Resorption.

@nl

prefLabel

Cepharanthine Prevents Estroge ...... by Inhibiting Bone Resorption.

@en

Cepharanthine Prevents Estroge ...... by Inhibiting Bone Resorption.

@nl

P1476

Cepharanthine Prevents Estroge ...... by Inhibiting Bone Resorption.

@en

P2093

Bin Hu

http://www.w3.org/2001/XMLSchema#string

Boon Chin Heng

http://www.w3.org/2001/XMLSchema#string

Chen-He Zhou

http://www.w3.org/2001/XMLSchema#string

Guang-Yao Jiang

http://www.w3.org/2001/XMLSchema#string

Hao-Bo Wu

http://www.w3.org/2001/XMLSchema#string

Jia-Hong Meng

http://www.w3.org/2001/XMLSchema#string

Jian Zhu

http://www.w3.org/2001/XMLSchema#string

Jian-Qiao Hong

http://www.w3.org/2001/XMLSchema#string

Kun Chen

http://www.w3.org/2001/XMLSchema#string

Le Cao

http://www.w3.org/2001/XMLSchema#string

P2860

The innate immune sensor NLRC3 attenuates Toll-like receptor signaling via modification of the signaling adaptor TRAF6 and transcription factor NF-κB

TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src

NLRC3 is an inhibitory sensor of PI3K-mTOR pathways in cancer

Osteoclast differentiation and activation

Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts

Low dose cepharanthine ameliorates immune thrombocytopenic purpura associated with multiple myeloma.

PTH[1-34] improves the effects of core decompression in early-stage steroid-associated osteonecrosis model by enhancing bone repair and revascularization.

Osteoclasts: more than 'bone eaters'.

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis

Emerging therapeutic opportunities for skeletal restoration.

P304

210

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2018.00210

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29636680

http://www.w3.org/2001/XMLSchema#string

P932

5880888

http://www.w3.org/2001/XMLSchema#string

Cepharanthine Prevents Estrogen Deficiency-Induced Bone Loss by Inhibiting Bone Resorption.

about

P2860

P2860

Cepharanthine Prevents Estrogen Deficiency-Induced Bone Loss by Inhibiting Bone Resorption.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932